What is the recommended EKG (electrocardiogram) protocol for an Elavil (amitriptyline) overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

EKG Protocol for Amitriptyline (Elavil) Overdose

In patients with suspected amitriptyline overdose, an immediate 12-lead ECG should be obtained and continuous cardiac monitoring initiated to assess for life-threatening arrhythmias and guide management. 1, 2

Initial ECG Assessment

Critical ECG Parameters to Evaluate:

  • QRS duration:

    • QRS ≥ 100 ms is common in TCA overdose (present in 82% of cases) 3
    • QRS > 120 ms has stronger association with arrhythmias (OR 4.83) 3
    • QRS ≥ 160 ms indicates severe toxicity 2
  • QT/QTc interval:

    • QTc > 500 ms is associated with increased arrhythmia risk (OR 3.07) 3
    • Document QTc before and after treatment interventions 1
  • Lead aVR findings:

    • R wave amplitude ≥ 3 mm in aVR (sensitivity 81% for predicting seizures/arrhythmias) 4
    • R/S ratio > 0.7 in aVR (strongest predictor, OR 16) 3, 4
    • Rightward axis shift in terminal QRS complex 2
  • Other ECG abnormalities:

    • Sinus tachycardia (present in 57.7% of pediatric cases) 5
    • ST-T wave changes 2
    • QT-U distortion, T wave alternans, enhanced U waves 1

Monitoring Protocol

  1. Immediate monitoring:

    • Obtain baseline 12-lead ECG immediately upon presentation 2
    • Initiate continuous cardiac monitoring 2
  2. Serial ECG assessment:

    • Document QTc in medical record using rhythm strip before treatment initiation 1
    • Repeat ECG at least every 8 hours during treatment 1
    • Additional ECGs after any change in clinical status or treatment interventions 1
  3. Duration of monitoring:

    • Continue ECG monitoring until drug levels have decreased and evidence of QT prolongation or associated arrhythmias is no longer present 1
    • Minimum six hours of observation with cardiac monitoring is necessary 2
    • Extended monitoring required if signs of toxicity occur at any time during the period 2

Management Based on ECG Findings

  • For QRS ≥ 0.10 seconds (indicating severity of overdose):

    • Administer IV sodium bicarbonate to maintain serum pH 7.45-7.55 2
    • Consider hyperventilation with frequent pH monitoring (avoid pH > 7.60) 2
  • For dysrhythmias unresponsive to sodium bicarbonate:

    • Consider lidocaine, bretylium, or phenytoin 2
    • Avoid Type 1A and 1C antiarrhythmics (e.g., quinidine, disopyramide, procainamide) 2
  • For Torsades de Pointes:

    • Administer IV magnesium sulfate 1
    • Replete potassium to 4.5-5 mEq/L 1
    • Consider ventricular pacing or isoproterenol for recurrent episodes 1

Special Considerations

  • ECG measurements alone should not be used as the sole criteria for risk assessment in TCA overdose 3
  • The predictive value of QRS ≥ 100 ms alone is limited (positive predictive value only 35%) 4
  • QRS > 120 ms has a 100% positive predictive value for coma in pediatric patients 5
  • R wave in aVR < 3 mm has a 100% negative predictive value for seizures in children 5
  • Case reports exist of patients succumbing to fatal dysrhythmias late after overdose, necessitating extended monitoring 2

Pitfalls to Avoid

  • Do not rely solely on plasma drug levels to guide management 2
  • Do not use QRS ≥ 100 ms or QRS ≥ 160 ms as the only predictor of arrhythmias 3
  • Do not discontinue monitoring prematurely, even if initial ECG appears normal
  • Do not transport patients with significant ECG abnormalities away from monitored settings 6
  • Do not use Type 1A and 1C antiarrhythmics (e.g., quinidine, disopyramide, procainamide) as they are contraindicated 2

By following this protocol, clinicians can effectively identify patients at highest risk for life-threatening arrhythmias and provide appropriate interventions to reduce morbidity and mortality in amitriptyline overdose.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.